Travere Therapeutics (NASDAQ:TVTX – Get Free Report) had its price objective increased by HC Wainwright from $17.00 to $19.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price objective points to a potential upside of 252.50% from the company’s current price. HC […]
Travere Therapeutics, Inc Expected to Earn FY2025 Earnings of ($1 80) Per Share (NASDAQ:TVTX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
There are now over 300 attendees registered for our upcoming insurance-linked securities (ILS) conference. ILS NYC 2024 will be held in New York City on
Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the ten brokerages that are covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has issued a strong buy recommendation […]
Snow Lake Management LP acquired a new position in YS Biopharma Co., Ltd. (NASDAQ:YSBPW – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 500,000 shares of the company’s stock, valued at approximately $78,000. YS Biopharma comprises 0.0% of Snow Lake Management […]